Lung Transplant: Clinical Trials

4 trials for Lung Transplant, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 enrolling by invitation, 1 terminated, 1 withdrawn. 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 34Completed 1, Enrolling by invitation 1, Terminated 1, Withdrawn 1

Follow Lung Transplant: new trials by email Literature Review of Lung Transplant trials Research Report on Lung Transplant

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Protest Trial: TXA vs Saline
Tranexamic Acid, Saline (placebo) - Lung Transplant, Complications Surgical
Phase 3Enrolling by invitationCorewell Health West942024-04-162026-07-21
CIS001 Extension Study of Cyclosporine Inhalation Solution
Cyclosporine Inhalation Solution (CIS) - Lung Transplant
Phase 3TerminatedAPT Pharmaceuticals, Inc.172009-12-012012-09-17
Study of Cyclosporine Inhalation Solution (CIS) in Improving Bronchiolitis Obliterans Syndrome-Free Survival Following Lung Transplantation
Cyclosporine Inhalation Solution (CIS) - Lung Transplant
Phase 3CompletedAPT Pharmaceuticals, Inc.2842008-09-012012-09-17
Intraoperative Versus Postoperative Thymoglobulin in Lung Transplantation
thymoglobulin (intraoperative), thymoglobulin (postoperative) - Lung Transplant
Phase 3WithdrawnUniversity of California, Los Angeles2006-01-012020-09-10

Narrower conditions

Bronchiolitis Obliterans (2)  ·  Bronchiolitis Obliterans Syndrome (2)  ·  Primary Graft Dysfunction (1)

Broader conditions

Bronchial Diseases (2)  ·  Bronchiolitis (2)  ·  Bronchitis (2)  ·  Graft vs Host Disease (2)  ·  Immune System Diseases (2)  ·  Lung Diseases (2)  ·  Lung Diseases, Obstructive (2)  ·  Organizing Pneumonia (2)  ·  Respiratory Tract Diseases (2)  ·  Cardiovascular Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Postoperative Complications (1)  ·  Reperfusion Injury (1)  ·  Vascular Diseases (1)

Interventions

Cyclosporine (1)  ·  Postoperative Period (1)  ·  Sodium Chloride (1)  ·  Tranexamic Acid (1)  ·  thymoglobulin (1)

Sponsors

APT Pharmaceuticals, Inc. (2)  ·  Corewell Health West (1)  ·  University of California, Los Angeles (1)

Countries

United States (4)  ·  Canada (2)

Top investigators

Bruce A Johnson, MD (1)  ·  Jeffrey Golden, MD (1)  ·  Rajan Saggar, MD (1)  ·  Stephen Dilly, MD PhD (1)

Results publications

PMID 23668548